Aethlon Medical Stock (NASDAQ:AEMD)
Previous Close
$1.97
52W Range
$1.75 - $8.48
50D Avg
$2.89
200D Avg
$3.62
Market Cap
$3.54M
Avg Vol (3M)
$25.71K
Beta
1.88
Div Yield
-
AEMD Company Profile
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
AEMD Performance
Peer Comparison
| Ticker | Company |
|---|---|
| SINT | Sintx Technologies, Inc. |
| RPID | Rapid Micro Biosystems, Inc. |
| NPCE | NeuroPace, Inc. |
| BBLG | Bone Biologics Corporation |
| VVOS | Vivos Therapeutics, Inc. |
| SRDX | Surmodics, Inc. |
| NUWE | Nuwellis, Inc. |
| TIVC | Tivic Health Systems, Inc. |
| BJDX | Bluejay Diagnostics, Inc. |
| DCTH | Delcath Systems, Inc. |
| HSCS | Heart Test Laboratories, Inc. |
| CVRX | CVRx, Inc. |